HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression
出版年份 2014 全文链接
标题
HER2 Status in Colorectal Cancer: Its Clinical Significance and the Relationship between HER2 Gene Amplification and Expression
作者
关键词
-
出版物
PLoS One
Volume 9, Issue 5, Pages e98528
出版商
Public Library of Science (PLoS)
发表日期
2014-05-31
DOI
10.1371/journal.pone.0098528
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Frequency of HER-2 Positivity in Rectal Cancer and Prognosis
- (2013) Lena-Christin Conradi et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- HER2 in high-risk rectal cancer patients treated in EXPERT-C, a randomized phase II trial of neoadjuvant capecitabine and oxaliplatin (CAPOX) and chemoradiotherapy (CRT) with or without cetuximab
- (2013) F. Sclafani et al. ANNALS OF ONCOLOGY
- The significance of the HER-2 status in esophageal adenocarcinoma for survival: an immunohistochemical and an in situ hybridization study†
- (2013) M. J. D. Prins et al. ANNALS OF ONCOLOGY
- HER2 and Breast Cancer Stem Cells: More than Meets the Eye
- (2013) H. Korkaya et al. CANCER RESEARCH
- Expression of HER2 in Colorectal Cancer Does Not Correlate with Prognosis
- (2013) Wiesław Janusz Kruszewski et al. DISEASE MARKERS
- HER2 and immunotherapy using monoclonal antibodies in colorectal cancer
- (2013) Ehsan Nazemalhosseini Mojarad et al. Immunotherapy
- Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer
- (2013) Eva Budinska et al. JOURNAL OF PATHOLOGY
- Clinical significance of intratumoral HER2 heterogeneity in gastric cancer
- (2012) Hee Eun Lee et al. EUROPEAN JOURNAL OF CANCER
- Microsatellite instability testing in Korean patients with colorectal cancer
- (2012) Jung Ryul Oh et al. Familial Cancer
- In situ analysis of HER2 mRNA in gastric carcinoma: comparison with fluorescence in situ hybridization, dual-color silver in situ hybridization, and immunohistochemistry
- (2012) Min A Kim et al. HUMAN PATHOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Gastroesophageal Cancer: Correlation Between Immunohistochemistry and Fluorescence In Situ Hybridization
- (2011) Laura J. Tafe et al. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
- HER2 status in gastro-oesophageal adenocarcinomas assessed by two rabbit monoclonal antibodies (SP3 and 4B5) and two in situ hybridization methods (FISH and SISH)
- (2011) James E. Boers et al. HISTOPATHOLOGY
- Cetuximab Plus Irinotecan, Fluorouracil, and Leucovorin As First-Line Treatment for Metastatic Colorectal Cancer: Updated Analysis of Overall Survival According to Tumor KRAS and BRAF Mutation Status
- (2011) Eric Van Cutsem et al. JOURNAL OF CLINICAL ONCOLOGY
- Assessment of ErbB2 (Her2) in oesophageal adenocarcinomas: summary of a revised immunohistochemical evaluation system, bright field double in situ hybridisation and fluorescence in situ hybridisation
- (2011) Rupert Langer et al. MODERN PATHOLOGY
- A Molecularly Annotated Platform of Patient-Derived Xenografts ("Xenopatients") Identifies HER2 as an Effective Therapeutic Target in Cetuximab-Resistant Colorectal Cancer
- (2011) A. Bertotti et al. Cancer Discovery
- Expression of Her-2 in Carcinomas of the Esophagus
- (2010) Sebastian F. Schoppmann et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Heterogenous high-level HER-2 amplification in a small subset of colorectal cancers
- (2010) Andreas H. Marx et al. HUMAN PATHOLOGY
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Is overexpression of HER-2 a predictor of prognosis in colorectal cancer?
- (2009) Dara O Kavanagh et al. BMC CANCER
- Improved Overall Survival With Oxaliplatin, Fluorouracil, and Leucovorin As Adjuvant Treatment in Stage II or III Colon Cancer in the MOSAIC Trial
- (2009) Thierry André et al. JOURNAL OF CLINICAL ONCOLOGY
- HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target
- (2008) C. Gravalos et al. ANNALS OF ONCOLOGY
- Assessment of a HER2 scoring system for gastric cancer: results from a validation study
- (2008) M Hofmann et al. HISTOPATHOLOGY
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal Cancer
- (2008) Christos S. Karapetis et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search